Загрузка...
New combinations in the treatment of COPD: rationale for aclidinium–formoterol
The current guidelines on chronic obstructive pulmonary disease (COPD) recommend the prominent use of bronchodilators, including long-acting β(2)-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs), while inhaled corticosteroids are recommended only in patients with severe disease or fre...
Сохранить в:
| Опубликовано в: : | Ther Clin Risk Manag |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4760652/ https://ncbi.nlm.nih.gov/pubmed/26929634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S82034 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|